Munger Mode rating: 2 out of 5 — Sell. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
$29.13 (52-week range $17.78–$31.65) 593.3M (Oct 26, 2026) $8.12B / $0.59B, so net debt is about $7.5B $2.93–$2.98, about 9.9x at the midpoint $0.50/yr, about 1.7% yield Gen is a good cash generator, and it is cheap on adjusted earnings. We still do not think it is a wonderful business. Consumer antivirus is a melting ice cube. The company is slowly replacing it with identity protection, and now with consumer fintech through MoneyLion. Fintech is a very different and much lower-quality line of business. The shares trade at roughly 10x the company's own adjusted EPS. That multiple tells you what the market thinks of the franchise's durability. We agree with the market on durability. Our calibration is firm: an average business at a fair price, carrying $8B of debt, is a 2-star stock. We would rather wait for a wonderful business, or for Gen at a much lower price.
Recent filings analysed: 10-Q (2026-10-29), 8-K (2026-10-28), 8-K (2026-10-09), 8-K (2026-09-28).
Stock screener · Superinvestor 13F holdings · Analyst sentiment